1.
Respir Med Case Rep
; 28: 100899, 2019.
Article
in English
| MEDLINE
| ID: mdl-31341763
ABSTRACT
We described three severe asthmatics whose asthma symptoms were rapidly improved by benralizumab following favorable response to mepolizumab. Benralizumab-induced eosinophil depletion contributed to clinical improvement of severe asthma after mepolizumab-induced eosinophil reduction; thus, prior favorable responses to mepolizumab may predict benralizumab efficacy.